| Sumario: | Introduction: Community-based hypertension programs are available worldwide. This review aims to summarise the cost-effectiveness of these programs to prevent and control hypertension. Material and Methods: We searched through three databases of PubMed, Scopus and Web of Science in November 2020. Published articles from 2010 through 2020 were screened. The community-based prevention programs were categorised into four groups: self-monitoring, educational interventions directed to the patient, educational interventions directed to the health professional and health professional (nurse or pharmacist) led care. Results: Eleven articles were included in the final review. All 11 articles conducted the programs of education intervention directed towards patients, seven articles conducted programs that include both self-monitoring and health professional (nurse or pharmacist) led care and only two studies conducted programs of which the educational interventions directed to the health professional. Six studies reported as cost per mm Hg reduction in systolic and/or diastolic blood pressure (ranging $0.69-$235.7 per mm Hg reduction), two studies reported as cost per DALY averted (ranging $349-$582) and three studies reported as cost per QALY gained (ranging $1257 - $4219). Conclusion: All studies showed the programs to be cost-effective. This information could provide the evidence base to guide the initiation and development of hypertension programmes.
|
|---|